Podcasts about Cardiology

This week we review a recent large scale PHIS database study on pericardial effusion following congenital heart surgery. Which operations other than ASD are most highly associated with the development of an effusion? What might be some approaches both surgically and medically to reduce the chances of these developing or requiring intervention? What are the implications of a pericardial effusion after surgery? How many require readmission for this complication? Dr. Mario O'Connor, who is a congenital heart surgical research fellow at UT Austin, shares his insights into his recent publication. DOI: 10.1177/21501351251322876

In this landmark 150th episode of Parallax marking the start of Season 8, Dr Ankur Kalra welcomes Professor Robert Bonow, Professor of Medicine and Cardiology at Northwestern University and Editor-in-Chief of JAMA Cardiology. This milestone conversation explores the career of one of cardiology's most influential academic leaders and examines how strategic vision, mentorship, and institutional leadership have shaped modern cardiovascular medicine. The discussion reveals the practical realities of building academic excellence through Dr Bonow's 33-year tenure at Northwestern University. He details the strategic approach to growing a cardiology division from 25 faculty members to over 70, emphasizing that success hinges on recruiting exceptional talent, providing institutional support, and granting faculty freedom to pursue their visions. Dr Bonow offers candid perspectives on academic leadership challenges and creating environments where innovation flourishes. Dr Bonow reflects on his influence through editorial and professional society leadership. As co-editor of seven editions of Braunwald's Heart Disease, he shares lessons from Dr Eugene Braunwald and discusses the evolution toward a digital "living textbook" responding in real-time to clinical evidence. His role founding JAMA Cardiology reveals strategic decisions required to establish a premier journal, while his progression through the American Heart Association - culminating in the presidency - demonstrates how sustained professional engagement amplifies individual impact. He closes with actionable guidance for early career cardiologists on recognizing opportunities, developing writing skills, and embracing the non-linear nature of successful careers. Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

This week we review a recent report on LV strain following the Ross operation. Can this sort of functional analysis help predict remodeling after aortic valve replacement? How can the type of Ross potentially affect heart function after the operation? Why might some parameters of LV strain improve but others not following surgery? Can preoperative strain measurements predict perioperative course? How does the addition of a Konno to a Ross change the outcomes of function? We speak with Chief of Cardiovascular Surgery at Primary Children's Hospital in Utah, Dr. S. Adil Husain and 3rd year integrated cardiac surgical resident Michal Schaffer of the University of Utah about these and other topics related to LV function following the Ross operation in children. ·         DOI: 10.1007/s00246-025-04124-9

The human heart is a tireless biomechanical marvel—an exquisitely engineered pump powered by both mechanical precision and an intrinsic electrical system, beating over 100,000 times a day to sustain life. But like any machine, despite having an electrical mind of its own, it is not infallible—when its rhythm drifts or its mechanics strain, the impact is felt far beyond the chest. From more complex cases like heart failure and detrimental arrhythmias to the more-known feared heart attack caused by high cholesterol, it leads to questions — What can we do to safeguard the health of our heart? What should one do when they experience chest pain? And how do we learn to listen to the heart's warning signs before they become life-altering events?In this episode, we are joined by Dr. Diala Steitieh, MD, a board-certified cardiologist and assistant professor of clinical medicine, focusing on hypertrophic cardiomyopathy and sports cardiology, based in New York City.Dr. Steitieh received her MD from Weill Cornell Medicine in Qatar and completed her Internal Medicine Residency and Cardiovascular Disease Fellowship at NewYork-Presbyterian Hospital/Weill Cornell Medical College. Currently, Dr. Steitieh serves as an Assistant Professor of Clinical Medicine and Principal Investigator of clinical studies at Weill Cornell Medical College and the Director of the Hypertrophic Cardiomyopathy Program in the Division of Cardiology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.Dr. Steitieh has been featured on Yahoo!, SELF Magazine, Qatar Tribune, MSN, TCTMD, and The Peninsula Qatar.Follow Friends of Franz Podcast: Website, Instagram, FacebookFollow Christian Franz (Host): Instagram, YouTube

Drs Harrington and Gibson's annual review of cardiovascular medicine: ACS guidelines, antiplatelet management, GLP-1s, and ever lower LDL-C with drugs or even gene editing are among the highlights. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington New ACS Guidelines 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes https://doi.org/10.1161/CIR.0000000000001309 ACS Guideline Chair and Vice-Chair Discussion https://www.medscape.com/viewarticle/acs-guidelines-2025-key-points-chair-and-vice-chair-2025a100093l Antiplatelet/Antithrombotic Strategies Prasugrel Beats Ticagrelor in High-Risk Patients With Diabetes After PCI https://www.medscape.com/viewarticle/prasugrel-beats-ticagrelor-high-risk-patients-diabetes-after-2025a1000wbt Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes (NEO-MINDSET) https://www.nejm.org/doi/full/10.1056/NEJMoa2507980 Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC) https://www.nejm.org/doi/full/10.1056/NEJMoa2507532 Bayesian Machine Learning Model Guiding Iterative, Personalized Anticoagulant Dosing Decision-Making : ENGAGE AF-TIMI 48 Trial Analysis https://doi.org/10.1016/j.jacadv.2025.102504 Factor XI Inhibitors Bristol Myers, J&J Stop Blood Clotting Drug Trial After Interim Review https://www.medscape.com/s/viewarticle/bristol-myers-j-j-stop-blood-clotting-drug-trial-after-2025a1000vqu Bayer's Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention https://www.bayer.com/en/us/news-stories/oceanic-stroke OAC-Naive Subgroup From OCEANIC-AF Published https://www.medscape.com/viewarticle/novel-blood-thinner-shows-promise-atrial-fibrillation-2025a10008lz GLP-1 and Myotrophic Drugs Lilly's Next-gen Drug Shows Greater Weight Loss Than Zepbound in Late-stage Trial (TRIUMPH-4) https://www.medscape.com/s/viewarticle/lillys-next-gen-drug-tops-zepbound-weight-loss-late-stage-2025a1000ys1 Amylin Analog Eloralintide Reduces Weight in Phase 2 Trial https://www.medscape.com/viewarticle/amylin-analog-eloralintide-reduces-weight-phase-2-trial-2025a1000uqf CRISPR and Lipid Lowering Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease https://www.nejm.org/doi/full/10.1056/NEJMoa2504747 Gene Therapy Shows Lipid Improvement but Raises Flags https://www.medscape.com/viewarticle/gene-therapy-shows-lipid-improvement-raises-flags-2025a1000uzw Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 https://www.nejm.org/doi/full/10.1056/NEJMoa2511778 Evolocumab in Patients without a Previous Myocardial Infarction or Stroke (VESALIUS-CV) https://www.nejm.org/doi/pdf/10.1056/NEJMoa2514428 Prehospital GLP IIb/IIIa Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction (CELEBRATE) https://evidence.nejm.org/doi/full/10.1056/EVIDoa2500268 You may also like: Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology https://www.medscape.com/twic Questions or feedback, please contact news@medscape.net

The TCTMD journalists look back at the year's memorable moments—and take a few guesses at what's ahead.

Patients with cardiomyopathy may benefit from virtual patient support groups. Guest Andrea Linder, RN, MSN, CCRC, FPCNA, describes a successful model, with sessions that include both information and opportunities to share their questions and experiences. Andrea also discusses recent clinical trials and the impact of mavacamten on disease management.Related PCNA Resources:Patient Education Tool on Hypertrophic Cardiomyopathy: https://pcna.net/resource/hypertrophic-cardiomyopathy-what-you-need-to-know-fact-sheet/HCP tool on Hypertrophic Cardiomyopathy: https://pcna.net/resource/hypertrophic-cardiomyopathy-what-healthcare-providers-need-to-know/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week we end 2025 with a Pediheart tradition - an episode on personal finance for medical professionals with noted authority on index investing and personal finance, Mr. Paul Merriman. Paul is a retired investment advisor who now has a popular podcast "Sound Investing" and website in which he offers advice on investing for 'do it yourself' investors. In this week's episode, the 5th of his visits to Pediheart, Mr. Merriman discusses 'factor investing' via index-like ETF's and funds. He also reviews who he believes might benefit from a financial advisor, what sort of advisor most should seek out and why he believes that many do not need one if they can 'stay the course'. Resources mentioned in today's podcast are below. Wishing all a happy and healthy new year in 2026. Paul's website:https://www.paulmerriman.com/#gsc.tab=0'Best In Class' ETF's:https://www.paulmerriman.com/Best-in-Class-ETF-Recommendations2025#gsc.tab=0Sound Investing 'Quilt Charts':https://irp.cdn-website.com/6b78c197/files/uploaded/(K)_Quilt_Charts_(1928-2024)_-_2024_Returns_(1).pdfDFA 'Turn Out The Noise':https://www.dimensional.com/filmAs a reminder, all of the information provided in this week's episode should be considered entertainment and all financial decisions should be vetted with professionals or knowledgeable and trusted friends/family. 

This week, Dr. Kahn shares his curated list of the top advances in heart research from 2025. He highlights key insights and perspectives from Drs. Kim Williams and Noel Merz, along with important updates from the American Heart Association. Dr. Kahn also reviews a newly published research paper on the 5-day Fasting Mimicking Diet (PROLON), including the first human evidence showing activation of autophagy. Learn what this could mean for metabolic and cardiovascular health. PROLON is available at prolonlife.com/drkahn. Thanks to tokuhealth.com/KAHN20 and their nattokinase product, Flow, for supporting the show.  Wishing everyone a healthy and happy holiday season and all the best in 2026.

2026 is coming in fast, and with it comes a fresh wave of CPT code changes that every healthcare professional needs to be ready for. On today's episode of the CodeCast podcast, we break down the newest updates impacting Cardiology, Peripheral Vascular services, and several other key specialties. From what's changing to why it matters, we'll walk through the revisions, additions, and potential pitfalls so you can stay compliant and ahead of the curve as the new year approaches. Subscribe and Listen You can subscribe to our podcasts via: Apple Podcasts – https://podcasts.apple.com/us/podcast/codecast-medical-billing-coding-insights/id1305926627 Spotify – https://open.spotify.com/show/1lA69Q7EnjSMuVr3sXVWlX TuneIn – https://tunein.com/radio/CodeCast–Medical-Billing-p1056702/ YouTube – https://www.youtube.com/channel/UCoNm5vs6PFMIEDa5Undidlg YouTube Music – https://www.youtube.com/playlist?list=PLQ8tk23yZroZslhtTVe-PEIjQsAoJZJIQ Pandora – https://www.pandora.com/podcast/codecast-medical-billing-and-coding-insights/PC:1000156874 Amazon Podcasts – https://music.amazon.com/podcasts/c9d8dc99-fced-45a2-82b4-0efdf144c897/CodeCast-Medical-Billing-and-Coding-Insights iHeart Radio – https://www.iheart.com/podcast/256-codecast-medical-billing-a-31135434/ The post 2026 CPT Code Changes Are Coming Fast appeared first on Terry Fletcher Consulting, Inc..

Updated Guidelines for Perioperative Cardiovascular Management for Noncardiac Surgery   Guest: Michael Cullen, M.D. Host: Kyle Klarich, M.D.   This episode of Mayo Clinic's “Interviews With the Experts” reviews the assessment of patients with known or suspected cardiovascular disease undergoing noncardiac surgery.  Dr. Michael Cullen discusses recommendations from 2024 ACC/AHA perioperative guidelines regarding medication management before and after noncardiac surgery, including recommendations for antiplatelet therapy and bridging anticoagulation.  Finally, he highlights new recommendations in the recent 2024 ACC/AHA perioperative guidelines and compare these guidelines to the 2022 European Society of Cardiology perioperative guidelines.   Topics Discussed: How should clinicians approach the assessment of a patient prior to noncardiac surgery? How should physicians and APPs manage cardiac medications around the time of noncardiac surgery? What are some of the new recommendations in the 2024 ACC/AHA guidelines for perioperative management prior to noncardiac surgery? How do the 2024 ACC/AHA perioperative guidelines differ from the 2022 ESC noncardiac surgery guidelines?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

On today's Good Day Health Show - ON DEMAND…Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken discuss “Holiday Heart,” AKA atrial fabulation (A-Fib) when the heart beats like a bag of worms and is caused by excessive drinking alcohol and binge-drinking. It can really lead to A-fib, put you in the hospital and ruin the festivities and celebration. Doug and Dr. Ken agree that alcohol is overrated. They aren't alone. Statistics indicate that fewer and fewer people are drinking and less alcohol is being sold than years prior. Then, the conversation switches to the flu and a rapidly increasing number of flu-related hospitalizations. This year, the flu is not a single strain, showing mutations allowing it to evade current flu vaccines. Shifting focus to longevity and health, Doug and Dr. Ken address research on populations with super-agers shows they don't eat a lot of meat. For instance, many in Japan who live mostly on fish products tend to live an average of at least 10 years longer than those who eat meats. Additionally, those who eat highly processed meats tend to live shorter lives. Listener questions addressed include heightened digestive problems due to the holidays, how do we know what medications are best for us and how to trust Big Pharma, and much more. Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

Roxana Mehran delves into the year's highlights with Michelle O'Donoghue.

Many clinicians quietly wonder if there's a “next chapter” beyond the hospital walls, and an increasing number are stepping into health tech roles that didn't exist a decade ago.Dr. Reena Pande has lived that shift firsthand: from cardiologist at a top academic center, to early employee and CMO at AbleTo, to now leading clinician executive search at Oxeon. She joins us to unpack what it really takes for clinicians to succeed in startups, why these roles matter more than ever, and how AI is reshaping both medical training and leadership.We cover:

What is a call? How does a person know if God is calling them to mission service? Join in a discussion as these and other questions are addressed.

The MI paradox of risk scores, the CELEBRATE trial of a new subcutaneous glycoprotein IIb/IIIA inhibitor (with its funny endpoint), the SURPASS CVOT trial, and the bad story of andexanet alfa are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I What do risk scores mean for individuals? Or perhaps a better question: Is a first MI preventable? Limitations of Screening in Predicting First MI https://www.jacc.org/doi/10.1016/j.jacadv.2025.102361 Sudden Death Due to Cardiac Arrhythmias https://www.nejm.org/doi/abs/10.1056/NEJMra000650 UMC Amsterdam group (EHJ) https://academic.oup.com/eurheartj/article/46/38/3762/8181058 II CELEBRATE Trial CELEBRATE Trial https://evidence.nejm.org/doi/full/10.1056/EVIDoa2500268 III SURPASS CVOT Trial Published Aug 01, 2025 This Week in Cardiology Podcast https://www.medscape.com/viewarticle/1002781 SURPASS-CVOT Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2505928 REWIND Trial 10.1016/S0140-6736(19)31149-3 External Link IV FDA Pulls Andexanet Alfa From the Market ANNEXA 4 https://www.nejm.org/doi/10.1056/NEJMoa1814051 ANNEXA I https://www.nejm.org/doi/full/10.1056/NEJMoa2313040 Richard Buka Tweet https://x.com/richardbuka/status/2001045834050216327?s=20 V Mandrola's Top Cardiovascular Stories of 2025 https://www.medscape.com/viewarticle/mandrolas-top-10-cardiovascular-stories-2025-2025a1000yuh You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we go back in time 2 years to review a recent paper from 2023 about outcomes of cardiac transplantation in the adult congenital heart patient (ACHD). Little has been written on this topic until this very robust and large scale report. How do single ventricle ACHD patients fair at transplant and how do they compare to non-ACHD heart transplant recipients? Why might 1 and 3 year outcomes not be a 'fair' method of assessing outcomes in this very high risk patient group? How do HLHS patient outcomes compare with other single ventricles? Are there better ways to measure risk in this patient group and how might the data in this work inform risk stratification and management of failing Fontan patients in whom transplantation is being considered? These are amongst the questions posed this week to the week's expert, Dr Daphne Hsu who is Professor of Pediatrics at the Albert Einstein College of Medicine at The Children's Hospital at Montefiore.https://doi.org/10.1016/j.jacc.2023.06.037For those interested in learning more about Dr. Hsu, take a listen to episode #166 from June, 2021:https://www.spreaker.com/episode/pediheart-podcast-166-a-conversation-with-professor-daphne-hsu--45144274

Food as Medicine: Dr. Elizabeth Klodas – Disrupting Cardiology with Clinical Nutrition Join us as we explore a critical question: What if the solution to America's number one killer isn't in the pharmacy, but in the kitchen? Today's guest is Dr. Elizabeth Klodas, a Mayo Clinic and Johns Hopkins-trained cardiologist who founded Step One Foods after realizing that doctors, including herself, weren't addressing the most powerful intervention for heart disease diet. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Sports cardiology is more than just heart care—it's about helping athletes thrive safely. In this episode, Le Bonheur Associate Chief of Cardiology Ranjit Philip, MD, answers common questions: Who needs a cardiology check before sports? What tests are involved? When should parents talk to a pediatrician? And what happens if a heart condition is discovered? We'll also share how Le Bonheur works with local colleges to support athletes at every level.  Learn more about Ranjit Philip, MD 

In the 200th episode of Health & Veritas, Harlan offers end-of-the-year reflections on medicine drawn from his editor's notes in JACC (the Journal of the American College of Cardiology), and Howie provides updates on gun violence, flu, measles, and the health benefits of yoga. Show notes: Editor's notes by Harlan Krumholz "The Day I Became a Doctor" "When Your Patient Dies" "Rethinking Physician Certification: A Call for a Modern, Meaningful Standard" Gun violence, flu, and measles "Mass shootings outnumber annual days in U.S., children are missing school due to measles, Covid-19 is peeping around the corner, and some hope" "Measles outbreaks worsen in South Carolina, Arizona and Utah" "Connecticut reports first measles case in years" "New Flu Variant May Be Triggering Spike in Severe Disease" "High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults" "Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance" The benefits of yoga "Yoga for chronic non‐specific low back pain" "Yoga-based interventions may reduce anxiety symptoms in anxiety disorders and depression symptoms in depressive disorders: a systematic review with meta-analysis and meta-regression" "Effect of Yoga on Frailty in Older Adults" "Yoga in autoimmune disorders: a systematic review of randomized controlled trials" "Long-term effects of yoga-based practices on neural, cognitive, psychological, and physiological outcomes in adults: a scoping review and evidence map" "Yoga isn't just for flexibility. It may also protect brain health." In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

The holidays can be good, and bad, for your heart. The vibes are good, the stress and food, not always. Hear more as Gordon Byrd speaks to University of South Florida cardiologist Dr. Bibhu Mohanty. See omnystudio.com/listener for privacy information.

Low resource settings require much innovation and streamlining resources to meet set goals. With healthcare becoming more commercial and profit driven, missional healthcare in low resource settings faces many challenges. Sustainability is a big question with people finance , and equipment scarce and hard to come by. Missional models of healthcare often run into hurdles of sustainability, longevity and relevance even as healthcare slowly turns into business. In this setting of multifactorial challenges and increasing compliances how can missional healthcare be relevant and sustainable? Many saints of God have committed their lives to fulfil this great commission in some of the most underserved and unreached areas of the world. With the birth of Emmanuel Hospital Association (EHA) a different model of missional healthcare emerged in India. Over the last 55 years of its existence, EHA has shown that through all the challenges, this may be one of the ways to sustain missional healthcare in areas of need. With increasing divide between the rich and poor, overwhelmed government systems, a ruthless insurance system, and high end corporate healthcare, it is still possible for missional healthcare to provide low cost, high quality, technologically advanced care to people in need while remaining sustainable. We bring lessons from India and our experience with Emmanuel Hospital Association over the last 3 decades.

Cardiovascular-Kidney-Metabolic (CKM) Syndrome leads to poor health outcomes, and is affecting individuals at younger and younger ages. The PREVENT calculator helps identify individuals earlier in the disease progression, allowing time for intervientions that may lead to a regression on the stages of CKM. Guest Chiadi Ndumele, MD, PhD. also describes shared decision-making, and value- and volume-based care models.PREVENT calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculatorPooled 10-year ASCVD Risk Calculator: https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/ 2025 Hypertension Guidelines Update: https://www.heart.org/en/health-topics/high-blood-pressure/the-facts-about-high-blood-pressure/high-bp-top-10AHA CKM Scientific Statement: https://professional.heart.org/en/science-news/cardiovascular-kidney-metabolic-health-a-presidential-advisoryPCNA CKM Resource list: https://pcna.net/resources/patient-education/patient-information/cardiovascular-kidney-metabolic-syndrome-resources/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On today's Good Day Health Show - ON DEMAND…Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken discuss the biggest news stories in the medical world, including a new osteoarthritis vaccine, a conversation on rheumatoid arthritis, and the season's illnesses going around with flu and norovirus. Then, the conversation shifts to a new inhaled form of insulin may help young people diagnosed with Type 1 Diabetes. This could help improve the quality of life in pediatric patients and minimize the uncontrolled complications from diabetes. Next up, the latest research on stem cell research, a discussion on plaque in arteries and a break through to minimize heart attacks and stroke, as well as a new pig liver transplant success story. Lastly, Doug and Dr. Ken answer listener questions like Agent Orange, worries about an enlarged prostate, and new clinical guidelines for front-of-package food labeling as associated with cardiovascular health. Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

Die Themen in den Wissensnachrichten: +++ In der Periode sind Verletzungen stärker +++ Emissionen durch trockengelegte Moore wohl deutlich unterschätzt +++ Wer traurig ist, achtet auf mehr Details +++**********Weiterführende Quellen zu dieser Folge:Menstruation and injury occurrence; a four season observational study in elite female football players; Frontiers in Sports and Active Living, 16.12.2025Identifying hotspots of greenhouse gas emissions from drained peatlands in the European Union, Nature Communications, 02.12.2025Unpleasant mood is linked to local processing in haptics, i-Perception, 11.12.2025Rank and social context influence sleep in wild chimpanzees, Current Biology, 12.12.2025What About Love? A Review of Interventions for Patients With Heart Disease and Their Intimate Partners: Recommendations for Cardiac Rehabilitation, Canadian Journal of Cardiology, 15.12.2025Alle Quellen findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok und Instagram .

Send us a message with this link, we would love to hear from you. Standard message rates may apply. In this episode of Your Checkup, we break down lipoprotein(a) — a largely inherited form of cholesterol that can significantly increase the risk of heart disease and stroke, even when standard cholesterol numbers look normal. We talk about what Lp(a) is, why it matters, who should be tested, and how it helps explain “unexpected” heart events in otherwise healthy people. While Lp(a) can't currently be lowered with diet or exercise, knowing your level allows you and your care team to be more intentional about prevention by aggressively managing other risk factors like LDL cholesterol, blood pressure, and diabetes. We also discuss what the numbers mean, why most people only need to be tested once, and the promising treatments currently being studied that may change care in the future. References (for Show Notes)Nordestgaard BG, Langsted A. Lipoprotein(a) and Cardiovascular Disease. Lancet. 2024;404(10459):1255-1264.Reyes-Soffer G, et al. AHA Scientific Statement on Lipoprotein(a). Arterioscler Thromb Vasc Biol. 2022;42(1):e48-e60.Di Fusco SA, et al. Lipoprotein(a): Risk Factor and Emerging Target. Heart. 2022;109(1):18-25.Nasrallah N, et al. Lp(a) in Clinical Practice. Eur J Clin Invest. 2025:e70127.Greco A, et al. Lipoprotein(a) as a Pharmacological Target. Circulation. 2025;151(6):400-415.Bess C, Mehta A, Joshi PH. All We Need to Know About Lipoprotein(a). Prog Cardiovasc Dis. 2024;84:27-33.Support the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

An elegant study in post-TAVI atrioventricular block, a PSA for my structural colleagues, revascularization in women, and a CTO PCI trial are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I AV Block After TAVR Heart Blocks During vs After TAVR Show Distinct Patterns https://www.medscape.com/viewarticle/heart-blocks-during-vs-after-tavr-show-distinct-patterns-2025a1000ypp Mechanisms Underlying Alterations in Cardiac Conduction After TAVR https://jamanetwork.com/journals/jamacardiology/fullarticle/2842748 II Related PSA Announcement to My Structural Colleagues III Revascularization Strategies in Women with Severe Chronic CAD Women With Chronic Severe CAD Fare Better With CABG vs PCI https://www.medscape.com/viewarticle/women-chronic-severe-cad-fare-better-cabg-vs-pci-2025a1000ygd PCI vs CABG in Women With Chronic CAD https://doi.org/10.1093/eurheartj/ehaf806 PCI vs CABG - Meta-Analysis of 4 RCTs https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02334-5/abstract CABG vs Drug-Eluting Stent Implantation for CAD - Meta-Analysis https://www.jacc.org/doi/10.1016/j.jcin.2016.10.008 RECHARGE trial https://therechargetrial.com/ IV A CTO PCI RCT – But don't get your hopes up Early vs Late-Staged PCI After Subintimal Tracking and Re-entry for CTO https://doi.org/10.1016/j.jacc.2025.09.1598 DECISION CTO trial https://pubmed.ncbi.nlm.nih.gov/30813758/ National Inpatient Sample Database PCI CTO Associated With Higher Mortality https://pubmed.ncbi.nlm.nih.gov/37356643/ V Mandrola's Top 10 Stories You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we speak with noted congenital cardiologist Professor Krishna Kumar of the Amrita Institute in Cochin, India and discuss his recent work on inequities in congenital heart care in the world. Over 90% of patients with CHD do not have access to care in the globe today. What is the path forward to improve this sobering statistic? How can a World Health Assembly resolution practically help improve care in LMIC countries worldwide? Dr. Kumar shares his deep insights.This week we also briefly note the passing of the wonderful and caring pediatric cardiologist Dr. Sangeetha Viswanathan of Chennai, India who tragically died suddenly this week while attending the World Congress events in Hong Kong. Dr. Kumar's words regarding his friend, former fellow and colleague are read in remembrance of this wonderful and giving cardiologist whose loss will be deeply felt by her patients, family and friends. DOI: 10.1016/j.jacc.2025.07.070

This week on Health Matters, Courtney is joined by Erin Welsh, host of NewYork-Presbyterian's medical research podcast, Advances in Care, to recap an amazing year of health and wellness conversations. They share highlights and discuss the top takeaways from their dozens of conversations with clinicians, researchers – and even a former New York Mets All-Star. This conversation is a great rundown of important health reminders and tips for all of us concerned with staying healthy during the holidays and starting the new year off on the right foot. ___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org

In this “Meet the Experts” HeartTalk episode, host Melanie Lawson, MS, talks with Jenny Kennedy, DNP, RN, CHFN, NEA-BC, FACC, vice president of Care Transformation Services at MedAxiom. She explains the importance of being intentional when setting up remote heart failure programs and lessons from her nursing experience. She shares how her desire to “be a giant”—lift others up rather than seek the spotlight—guides her leadership. Additionally, she reflects on the spirit of Florence Nightingale, offering insights that may shift your view of team-based care and the future of cardiology.Guest Bio:Jenny KennedyDNP, RN, CHFN, NEA-BC, FACCVice President of Care Transformation Services, MedAxiomAs Vice President of Care Transformation Services at MedAxiom, Jenny advises cardiovascular programs and industry organizations across the country on clinical pathways, guideline implementation, quality improvement, operations, disease-specific certification, remote management, strategic planning and more. She is passionate about developing programs that span the care continuum and serve those with complex health diseases to benefit communities, patients and care providers. She encourages innovation and understands the importance of building relationships with mutual trust to empower high-performing teams that can change the lives of the communities they serve.Jenny brings nearly 20 years of clinical and leadership experience in the healthcare field, with a focus in cardiology, to her role at MedAxiom. Prior to joining the team, Jenny was the director of heart failure and electrophysiology at Wellstar Health System in the metropolitan Atlanta area. She has vast experience with clinic operations, cardiology and specialty clinics, and coordination of programs that span the care continuum.Jenny holds a Doctorate of Nursing Practice, a Master of Science in Nursing specializing in healthcare system leadership, and a Bachelor of Science in Nursing. A lifelong learner, she holds Certified Heart Failure Nurse and Nurse Executive Advanced Certifications. She is also an active member of the Association of Heart Failure Nurses.

Learn more and register for Fetch Encore here. On this week's episode of The Vet Blast Podcast presented by dvm360, host Adam Christman, DVM, MBA, welcomes Derek Matthews, DVM, DACVIM (Cardiology) to talk about Felycin-CA1, including its benefits, what previous studies have shown, and how it actually works. 

Moins connue que la ménopause, l'andropause est une période au cours de laquelle la sécrétion de testostérone diminue chez l'homme. Baisse de la libido, fatigue, augmentation du risque cardiovasculaire, irritabilité, augmentation du tour de taille… Les symptômes de l'andropause sont nombreux. Contrairement à la ménopause qui touche toutes les femmes, l'andropause n'affecte qu'une faible proportion d'hommes âgés. Comment se fait le diagnostic ? Quelle prise en charge existe ?  Si, du côté des femmes, les effets et ressentis associés à la ménopause sont abordés plus ouvertement qu'il y a quelques années, chez les hommes, l'andropause reste encore largement méconnue et rarement évoquée publiquement. Pourtant, les changements hormonaux liés au vieillissement impliquent un certain nombre de conséquences pour la santé et le bien-être des hommes. La baisse du taux de testostérone peut entraîner de multiples symptômes.  Andropause : ménopause au masculin ?  Certains spécialistes (urologue, endocrinologue, andrologue...) peuvent orienter le patient vers des analyses pour évaluer le taux de testostérone sanguin. La chute des androgènes peut provoquer une série de symptômes tels que des troubles de la fonction érectile, une baisse de la libido, une prise de poids, des troubles de l'humeur et du sommeil… Alors si certains symptômes se retrouvent chez l'homme et la femme, passé un certain âge, ménopause et andropause se distinguent par un simple fait : son caractère systématique chez la femme, autour de la cinquantaine (avec l'arrêt des règles, qui annonce la fin de la fonction reproductrice), quand, chez l'homme, ce déficit d'hormones sexuelles mâles lié à l'âge n'est pas systématique.  En finir avec le non-dit  La prise en charge de l'andropause repose sur des mesures hygiéno-diététiques : activité physique, alimentation équilibrée, baisse de la consommation d'alcool... Pour certains hommes, une supplémentation en testostérone pourra être prescrite, associée à un suivi médical. D'où l'importance de dépasser le tabou : oser en parler, pour trouver, si besoin, des solutions auprès d'un spécialiste.  Avec : Pr François Desgrandchamps, chef du service d'Urologie de l'Hôpital Saint-Louis de Paris, et professeur d'Urologie, à l'Université Paris Cité.   Dr Oumar Gaye, urologue-andrologue au Centre Hospitalier National Dalal Jamm, à Dakar, au Sénégal.   Un reportage de Raphaëlle Constant.  ► En fin d'émission, nous faisons un point sur l'étude de l'Inserm à Paris, publiée dans The Journal of the American College of Cardiology qui fait état du fardeau que représente l'hypertension artérielle en Afrique subsaharienne. Interview du Dr Aboubakari Nambiema, chercheur en Santé publique à l'Inserm au Centre de recherche cardiovasculaire de Paris et au sein de l'Unité de Recherche en Santé des Populations (URESAP) à Lomé au Togo.  Programmation musicale : ► Olivia Dean - Man I need ► Lëk Sèn - Shine.

Moins connue que la ménopause, l'andropause est une période au cours de laquelle la sécrétion de testostérone diminue chez l'homme. Baisse de la libido, fatigue, augmentation du risque cardiovasculaire, irritabilité, augmentation du tour de taille… Les symptômes de l'andropause sont nombreux. Contrairement à la ménopause qui touche toutes les femmes, l'andropause n'affecte qu'une faible proportion d'hommes âgés. Comment se fait le diagnostic ? Quelle prise en charge existe ?  Si, du côté des femmes, les effets et ressentis associés à la ménopause sont abordés plus ouvertement qu'il y a quelques années, chez les hommes, l'andropause reste encore largement méconnue et rarement évoquée publiquement. Pourtant, les changements hormonaux liés au vieillissement impliquent un certain nombre de conséquences pour la santé et le bien-être des hommes. La baisse du taux de testostérone peut entraîner de multiples symptômes.  Andropause : ménopause au masculin ?  Certains spécialistes (urologue, endocrinologue, andrologue...) peuvent orienter le patient vers des analyses pour évaluer le taux de testostérone sanguin. La chute des androgènes peut provoquer une série de symptômes tels que des troubles de la fonction érectile, une baisse de la libido, une prise de poids, des troubles de l'humeur et du sommeil… Alors si certains symptômes se retrouvent chez l'homme et la femme, passé un certain âge, ménopause et andropause se distinguent par un simple fait : son caractère systématique chez la femme, autour de la cinquantaine (avec l'arrêt des règles, qui annonce la fin de la fonction reproductrice), quand, chez l'homme, ce déficit d'hormones sexuelles mâles lié à l'âge n'est pas systématique.  En finir avec le non-dit  La prise en charge de l'andropause repose sur des mesures hygiéno-diététiques : activité physique, alimentation équilibrée, baisse de la consommation d'alcool... Pour certains hommes, une supplémentation en testostérone pourra être prescrite, associée à un suivi médical. D'où l'importance de dépasser le tabou : oser en parler, pour trouver, si besoin, des solutions auprès d'un spécialiste.  Avec : Pr François Desgrandchamps, chef du service d'Urologie de l'Hôpital Saint-Louis de Paris, et professeur d'Urologie, à l'Université Paris Cité.   Dr Oumar Gaye, urologue-andrologue au Centre Hospitalier National Dalal Jamm, à Dakar, au Sénégal.   Un reportage de Raphaëlle Constant.  ► En fin d'émission, nous faisons un point sur l'étude de l'Inserm à Paris, publiée dans The Journal of the American College of Cardiology qui fait état du fardeau que représente l'hypertension artérielle en Afrique subsaharienne. Interview du Dr Aboubakari Nambiema, chercheur en Santé publique à l'Inserm au Centre de recherche cardiovasculaire de Paris et au sein de l'Unité de Recherche en Santé des Populations (URESAP) à Lomé au Togo.  Programmation musicale : ► Olivia Dean - Man I need ► Lëk Sèn - Shine.

On today's Good Day Health Show - ON DEMAND…Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken discuss the biggest news stories in the medical world, starting with a discussion on a new treatment for Hereditary Hemorrhagic Telangiectasia (HHT), which is good news for people who suffer from this rare mality, the a proof of concept trial for a new oral therapy for those who deal with severe and recurrent nose bleeds and internal bleeding. In the past, there was no treatment for this, so this is great news and a wonderful step forward for those with HHT. Next up, in Respiratory Syncytial Virus (RSV) news, preventative measures are being tested so that newborns, who are most susceptible, will have a better chance at prevention of acute lung conditions as well as lifelong lung condition of asthma. RSV immunizations can help prevent future children from developing asthma. Then, Doug and Dr. Ken discuss new guidelines for obesity drugs around the world with the World Health Organization (WHO) releasing global guidelines on GLP-1s with key recommendations warning that the medications should not be a stand alone solution. Weight loss drugs should be incorporated into a comprehensive care plan that includes diet and physical activity. WHO also goes into highlighting concerns of global equity, cost and longterm data gaps. The conversation shifts to a study on “beer bellies,” and what it means for heart health and risks, especially in men. Belly fat seems to be linked to changes in heart structure that contribute to heart failure. The heart muscle itself thickens without the heart itself increasing in size, which leads to a smaller volume of blood able to be pumped out of the heart. Another item of obesity has to do with youngsters and the correlation of pre-teens spending too much Tim eon their phones, leading to less time spent with physical activity. This leads to increased risk of depression, obesity, and lower sleep qualities. Other news includes a new treatment for spinal problems, the FDA's granted accelerated approval for a drug treatment for adults with primary IgA Nephropathy, a study on fame being a killer, whether or not shoulder surgery benefits outweigh the risks involved, and new conclusions of a link between acetaminophen (Tylenol being the most famous brand) and whether or not it's causing autism or ADHD in children when the mother used the drug during pregnancy.  Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

Less is more after PCI, the TARGET-FIRST trial, a negative blood pressure trial that is actually positive, aspirin vs OAC for bleeding, AEDs, and Factor XI is not dead yet are the topics discussed by John Mandrola, MD, on this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Less is More: TARGET-FIRST TARGET-FIRST Trial https://www.nejm.org/doi/10.1056/NEJMoa2508808 STOPDAPT-2 ACS Trial https://jamanetwork.com/journals/jamacardiology/fullarticle/2789701 II A Negative Trial That Is Actually Positive The RETREAT-FRAIL Study https://www.nejm.org/doi/full/10.1056/NEJMoa2508157 III Major Bleeding With Aspirin vs Apixaban Subanalysis of ARTESiA https://jamanetwork.com/journals/jamacardiology/fullarticle/2841075 ARTESiA Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2310234 AVERROES Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1007432 IV High Value Interventions – The AED Experts Call for AED Placement on All Commercial Aircraft https://www.medscape.com/viewarticle/experts-call-aed-placement-all-commercial-aircraft-2025a1000xzf In-Flight Sudden Cardiac Arrest and AED Use 10.1016/j.cjca.2025.10.010 External Link V Factor XI Inhibitors – OCEANIC STROKE trial Bayer Press Release on Asundexian https://www.bayer.com/en/us/news-stories/oceanic-stroke You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

ECMO is the topic of this week's episode of Pediheart. We speak with Assistant Professor of Pediatrics and cardiac critical care specialist at Northwell Health, Dr. Ivana Capin about a recent ELSO database study she conducted to assess outcomes in single ventricle patients who were treated with ECMO prior to single ventricle palliation. What factors were associated with worse overall outcomes? Can this therapy be used to stabilize the HLHS patient with an intact atrial septum? Why have outcomes for this high risk patient group not appreciably improved in the recent decade? How can these data improve prognostic clarity when speaking with families in this difficult situation.Also joining us briefly is Associate Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai, Dr. Scott Aydin to discuss his co-author and mentor, Dr. George Ofori-Amanfo as we approach the 4th anniversary of his untimely and tragic passing. DOI: 10.1017/S1047951125001386

Dr. John Osborne of Clear Cardio, a Preventative Cardiologist, sits down with intuitive healer, psychic medium, and wellness expert Laura Michelle Powers for a fascinating conversation about the connection between intuition, health, and the heart.Laura shares her powerful journey—from earning a master's degree in political science and working in government to facing a major health crisis that led her to rediscover her intuitive gifts and realign her life purpose. Laura and Dr. Osborne explores how emotional stress and energetic imbalance can affect physical health, why meditation and stillness are essential to healing, and how listening to your intuition can help you prevent illness and find greater peace.Dr. John Osborne is not your typical cardiologist.He's one of fewer than 50 Cardiologist out of 33,000 in the U.S. triple board-certified in Cardiology, Lipidology, and Hypertension — and one of only a handful globally trained to interpret the most advanced heart imaging on the planet.But what truly sets him apart is how he practices.With a PhD in Cardiovascular Physiology and more than 25,000 advanced heart scans performed, Dr. Osborne has spent the last 25 years developing a completely different approach to heart health — one that's holistic, non-invasive, and deeply human.He's the co-founder of ClearCardio™, a revolutionary prevention-first annual heart disease, detection and treatment practice that detects disease before symptoms show up — and reverses it without surgery or scare tactics.His method blends AI-powered diagnostics with lifestyle medicine, medication precision, and deep listening. He looks at the full person — genetics, stress, sleep, hormones, nutrition, environment — not just lab numbers.He believes heart attacks are largely preventable.And that your body, when given the right tools, already knows how to heal.Learn more at https://clearcardio.com/Laura is a Celebrity Psychic who has been featured by Buzzfeed, The Weakest Link, Beast Games, NBC, ABC, CBS, FOX, the CW, Motherboard by Vice Magazine and the #1” Ron Burgundy Podcast” with Will Ferrell. Laura Powers is a clairvoyant, psychic medium, writer, actress, producer, writer, and speaker who helps other receive guidance and communicate with loved ones. Laura travels nationally and internationally for clients, events, television appearances, and speaking engagements. She is also the author of 7 books on the psychic realm and 1 book on podcasting. Laura also works as a psychic, entertainer, and creative entrepreneur.For more information about Laura and her work, you can go to her website www.healingpowers.net or find her on X @thatlaurapowers, on Facebook at @realhealingpowers and @mllelaura, and on Instagram, TikTok and Insight Timer @laurapowers44.

Send us a textDr. Sara Collins joins Dr. Michael Koren to talk about her journey as a research cardiologist. They discuss Dr. Collins's path through preparatory school, college, med school, and the post-school experience as a cardiologist. They also discuss her role starting a clinical research site in Washington, D.C., and her efforts to leverage the research apparatus to provide equitable care to otherwise disadvantaged and underserved communities. Dr. Collins talks about how there is a racial disconnect in care in spite of the typically good insurance coverage in the D.C. area.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Afib is on the rise with significant effects on morbidity and mortality. Afib is a progressive disease with various treatment methods to match to your patients' risk factors and health goals. Stroke prevention is a crucial risk factor to evaluate on the progressive journey of a patient experiencing Afib. Learn more about the assessment and identification of patients with Afib at risk for stroke and next steps in prevention.https://www.ahajournals.org/doi/10.1161/CIR.0000000000001193https://chads2vasccalculator.com/https://www.uptodate.com/contents/image?imageKey=HEME%2F75259https://pcna.net/resource/afib-prepare-for-your-next-visit-discussion-guide/https://pcna.net/resource/the-beat-goes-on-living-with-atrial-fibrillation-online-interactive-patient-guide/https://pcna.net/resource/afib-and-stroke-infographic/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Afib is on the rise with significant effects on morbidity and mortality. The stagnation of blood in the left atrium and left atrial appendage (LAA) places patients at risk for thromboembolism and stroke. By ligating or closing off the LAA, the risk can be significantly reduced. This intervention offers a valuable alternative to medication, improving safety and quality of life for patients through a minimally invasive, durable stroke prevention strategy. Learn more about the procedure and steps for referring your eligible patient. https://chads2vasccalculator.com/https://www.watchman.com/en-us-hcp/oac-alternative.html?utm_source=oth_site&utm_medium=display-direct&utm_campaign=ic-wm-us-dtr-hcp_app&utm_content=pcna_podcast_oac_alternative-n-n-n&cid=dsp10020937https://www.watchman.com/en-us-hcp/patient-selection-referrals/patient-pre-screening-tool.html?utm_source=oth_site&utm_medium=display-direct&utm_campaign=ic-wm-us-dtr-hcp_app&utm_content=pcna_podcast_patient_screener-n-n-n&cid=dsp10020938https://pcna.net/resource/afib-prepare-for-your-next-visit-discussion-guide/https://pcna.net/resource/the-beat-goes-on-living-with-atrial-fibrillation-online-interactive-patient-guide/https://pcna.net/resource/afib-and-stroke-infographic/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week we go back in time to 2020 to delve into the topic of fellow wellness and review a work from the Boston Children's group on fellow fears and stressors when beginning their training. Are there patterns amongst the fellow concerns that can be identified and used to inform interventions to help allay these fears and reduce the stress? We speak with Dr. David Brown, Associate Professor of Pediatrics, Harvard Medical School and also Dr. Tony Pastor who was then the ACHD Fellow at Boston Children's Hospital/Brigham and Women's Hospital about their thoughts on fellow fears and stressors as well as fellow (and doctor) wellness. doi: 10.1007/s00246-019-02276-z.

Dr. Linda Chu hosts a conversation with Dr. Chiara Bucciarelli-Ducci, Dr. Tim Leiner, and Gwenael Herigault on the latest innovations in cardiac MRI. They discuss how AI-driven workflow automation and helium-free systems are improving access, efficiency, and collaboration between radiologists and cardiologists. The episode also explores how advances in training, technology, and teamwork are enhancing care for cardiovascular patients. Sponsored by Philips Healthcare.

Discover how artificial intelligence is revolutionizing heart disease prevention and treatment with Dr. Ami Bhatt, Chief Innovation Officer at the American College of Cardiology.From AI-powered early detection tools to personalized risk prediction, learn how new technologies are making quality cardiac care more accessible while preserving the essential human element of medicine. Dr. Bhatt shares fascinating insights about the innovations transforming cardiovascular health today and her vision for even more remarkable advances coming in the next five years.You can find Ami at: Website | LinkedIn | Episode TranscriptIf you LOVED this episode, don't miss a single conversation in our Future of Medicine series, airing every Monday through December. Follow Good Life Project wherever you listen to podcasts to catch them all.Check out our offerings & partners: Join My New Writing Project: Awake at the WheelVisit Our Sponsor Page For Great Resources & Discount Codes Hosted on Acast. See acast.com/privacy for more information.

Listener feedback, huge news in the world of carotid disease with the CREST-2 publication, prasugrel beats ticagrelor again, and a big coffee trial are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback Complete Revascularization for Acute MI Meta-analysis  https://doi.org/10.1016/S0140-6736(25)02170-1 II A Sea Change in the Treatment of Carotid Artery Disease — CREST-2 Published ECST-2 https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00107-3/fulltext SPACE-2 https://pubmed.ncbi.nlm.nih.gov/36115360/ CREST-2 Trial www.nejm.org/doi/full/10.1056/NEJMoa2508800 CREST Protocol paper https://pmc.ncbi.nlm.nih.gov/articles/PMC5987521/ III Prasugrel Beats Ticagrelor in High-Risk Patients With Diabetes After PCI https://www.medscape.com/viewarticle/prasugrel-beats-ticagrelor-high-risk-patients-diabetes-after-2025a1000wbt PLATO trial https://www.nejm.org/doi/full/10.1056/NEJMoa0904327 Ticagrelor or prasugrel vs clopidogrel in PCI https://eurointervention.pcronline.com/article/ticagrelor-or-prasugrel-versus-clopidogrel-in-patients-undergoing-percutaneous-coronary-intervention-for-chronic-coronary-syndromes ISAR-REACT 5 trial https://www.nejm.org/doi/full/10.1056/NEJMoa1908973 IV Another Coffee and AF study Can Coffee Cut the Risk for Atrial Fibrillation? https://www.medscape.com/viewarticle/can-coffee-cut-risk-atrial-fibrillation-2025a1000w11 A Coffee a Day to Keep the AFib Away? The DECAF Trial Discussed https://www.medscape.com/viewarticle/coffee-day-keep-afib-away-decaf-trial-discussed-2025a1000v5z DECAF trial https://jamanetwork.com/journals/jama/fullarticle/2841253 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we review the topic of mitral annular disjunction ("MAD") and the possible association with ventricular arrhythmia or sudden death in the connective tissue disease patient. Is there a 'cut off' distance above which patients deserve more significant arrhythmia surveillance? What is the best way to measure the MAD distance? Can patients with low MAD distances have lower degrees or even no arrhythmic surveillance? How often should this distance be measured on CMR and can an echo measurement provide similar data? Dr. Daniel Castellanos, the first author of this work and Assistant Professor of Pediatrics at Harvard Medical School shares his deep insights this week.DOI: 10.1016/j.jocmr.2025.101954

Susan Matulevicius, MD, MSCS, a national expert on resilience and work-life integration, joins the Faculty Factory Podcast this week for a discussion to help us better deal with life's inevitable stumbling blocks. Dr. Matulevicius serves as Associate Dean of Faculty Wellness and is a Professor of Internal Medicine, Cardiology, at the UT Southwestern Medical Center in Dallas. To help us think about how to create professional well-being in academic medicine, she discusses the 5 Ps: Person Purpose Path Prioritization Permission “When you get down to it, our values generally align with our purpose, and it helps us refocus when we encounter those little stumbling blocks that life puts in our way,” she said. She also touches on the value of understanding your purpose in relation to Self-Determination Theory, which is an important paradigm related to this conversation. With reassurance, Dr. Matulevicius warmly reminds us midway through the conversation of something we all need to hear occasionally: “Sometimes it's okay to not be okay." “Life and work are not always predictable, and sometimes your emotions aren't predictable in the moment. It's okay to recognize that you need more support to help you through that moment,” she said.  Learn More: https://facultyfactory.org/Susan-Matulevicius

In this episode, Dr. Amro Alsaid, Medical Director of Advanced Cardiac Imaging, and Dr. Karim Al-Azizi, Medical Director of the Catheterization Laboratory and Structural Heart Program at Baylor Scott & White The Heart Hospital, discuss how AI and advanced cardiac imaging are reshaping coronary diagnosis, improving precision in patient care, and optimizing workflow efficiency across cardiology programs.Visit Cleerly Health to learn more. https://cleerlyhealth.com/what-is-cleerly?utm_campaign=cleerly_brand&utm_medium=podcast&utm_source=beckers&utm_content=pr-podcast-11-2025

Listener feedback on the PISCES trial, AHA news (including a big PCSK9i trial), beta-blockers post MI, LAAC, and post-AF ablation OAC use are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback Why I Believe Fish Oil's Big CV Benefit in Dialysis Patients https://www.medscape.com/viewarticle/why-i-believe-fish-oils-big-cv-benefit-dialysis-patients-2025a1000uzg PISCES trial https://www.nejm.org/doi/full/10.1056/NEJMoa2513032 II PCSK9 Inhibitor News In Global Trial, PCSK9 Inhibitor Provides Major Protection Against First CV Event https://www.medscape.com/viewarticle/global-trial-pcsk9-inhibitor-provides-major-protection-2025a1000uzp VESALIUS-CV trial https://www.nejm.org/doi/full/10.1056/NEJMoa2514428 ODYSSEY trial https://www.nejm.org/doi/full/10.1056/NEJMoa1801174 FOURIER https://www.nejm.org/doi/full/10.1056/NEJMoa1615664 Anish Koka Tweet on LDL-lowering https://x.com/anish_koka/status/1987280506937909326?s=20 III Beta-Blockers After MI and John Cleland Beta-Blockers after MI with normal EF https://www.nejm.org/doi/full/10.1056/NEJMoa2512686 REBOOT-CNIC trial https://www.nejm.org/doi/full/10.1056/NEJMoa2504735 REDUCE AMI trial https://academic.oup.com/ehjcvp/article/9/2/192/6895544?login=false ABYSS trial https://www.nejm.org/doi/full/10.1056/NEJMoa2404204 CAPITAL RCT trial https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199347 Beta-Blockers after MI with mildly reduced EF https://pubmed.ncbi.nlm.nih.gov/40897190/ John Cleland Clinical Outlook https://www.nature.com/articles/s41569-025-01228-w IV Left Atrial Appendage Closure – The CLOSURE-AF trial Percutaneous LAAC in AF Falls Short Again in CLOSURE-AF https://www.medscape.com/viewarticle/percutaneous-left-atrial-appendage-closure-af-falls-short-2025a1000uzu Prague-17 Trial https://www.jacc.org/doi/10.1016/j.jacc.2020.04.067 OPTION trial https://www.nejm.org/doi/full/10.1056/NEJMoa2408308 V Oral AC after AF ablation – the OCEAN Trial Anticoagulation After AF Ablation: The OCEAN Trial Still Leaves Questions https://www.medscape.com/viewarticle/anticoagulation-after-af-ablation-ocean-trial-still-leaves-2025a1000v4t OCEAN Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2509688 ALONE-AF trial https://jamanetwork.com/journals/jama/fullarticle/2838294 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we review a recent retrospective review from Phoenix Children's Hospital about coronary artery fistulae. How common are they and who needed intervention? How should the cardiologist think about the small fistula? Should they all be ‘followed' or can they be discharged from cardiology follow-up? How small is ‘small enough'? We speak with Dr. Marie Chevenon who is a fetal cardiologist at Phoenix Children's Hospital about her recent study on the Phoenix experience with coronary artery fistulae.  https://doi.org/10.1007/s00246-024-03600-y

Listener feedback on non-culprit PCI in STEMI, a major cardiac result in patients on hemodialysis, news on GLP-1 agonists, a dubious stroke trial, and an AHA preview are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback Meta-analysis of MI as a surrogate https://pubmed.ncbi.nlm.nih.gov/34694318/ Compare Acute Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1701067 DANAMI-3–PRIMULTI 10.1016/S0140-6736(15)60648-1 External Link CULPRIT-SHOCK https://www.nejm.org/doi/full/10.1056/NEJMoa1710261   II  Huge Cardiac News for Patients with ESRD PISCES article EMBARGOED Till 1130 AM EST PISCES Trial www.nejm.org/doi/full/10.1056/NEJMoa2513032 REDUCE-IT Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1812792 STRENGTH Trial https://jamanetwork.com/journals/jama/fullarticle/2773120 FISH trial https://jamanetwork.com/journals/jama/fullarticle/1150094 III Obesity Agents White House announces deal with Lilly and Novo on GLP-1 drugs https://www.reuters.com/business/healthcare-pharmaceuticals/novo-lilly-shares-rise-trump-obesity-drug-deal-nears-2025-11-06/ Amylin Agonists Amylin Analog Eloralintide Reduces Weight in Phase 2 Trial https://www.medscape.com/viewarticle/amylin-analog-eloralintide-reduces-weight-phase-2-trial-2025a1000uqf Eloralintide Phase 2 Study https://doi.org/10.1016/S0140-6736(25)02155-5 GLP-1 Comparisons SURMOUNT-5 Trial https://www.nejm.org/doi/10.1056/NEJMoa2416394 Tirzepatide vs Semaglutide in 10-year CVD Risk Reduction https://doi.org/10.1093/ehjopen/oeaf117 IV A Problematic Trial in Stroke Care LAMP trial https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2840370 V AHA Preview AHA 2025: Mandrola's Four Trials to Look For https://www.medscape.com/viewarticle/aha-2025-mandrolas-four-trials-look-2025a1000u80 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net